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Background 
Intraoperative Hypotension (IOH) is common after spinal anesthesia 
(SA) and is associated with an increased risk of end organ damage.1 
2 3 The treatment regimen for IOH after SA varies in the orthopedic 
population. However, the current research literature suggests that a 
prophylactic infusion of phenylephrine significantly reduces the 
number of episodes and duration of hypotension.1
This EBP project aims to report the proportion of patients receiving 
prophylactic phenylephrine infusions and the incidence of
hypotension following SA among orthopedic surgery patients at 
Providence Sacred Heart Medical Center (PSHMC) in Spokane, WA.
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• A retrospective, observational EBP project was conducted at 
PSHMC.
• Permission was obtained by PSHMC Clinical Innovation and 
Research Council and deemed exempt from human subjects
research by the Providence Health Care Institutional Review 
Board. 
• Patient data was securely extracted, deidentified, and stored in a 
HIPPA compliant REDCap database.
• Inclusion criteria: Adult patients ≥ 18 years old who received SA 
for non-emergent orthopedic surgery.
• Exclusions: Pediatric, obstetric, emergency surgery, and surgery 
lines other than orthopedic.
• IOH outcome determined by absolute mean arterial pressure 
(MAP) thresholds, as described in Wesselink et al. (2018) 
systematic review.4     
• Descriptive analyses were conducted to examine baseline 
demographics and IOH treatment regimens utilized at PSHMC. 
• Independent risk factors determined using binary logistic 
regression and time-to-event (MAP <60 mmHg) analyses 
determined using the Kaplan-Meier estimator (α = 0.05).
The primary objective of this observational EBP project of 3,745 
patients was to measure the use of prophylactic phenylephrine 
infusions among orthopedic surgery patients at PSHMC. Overall,  
we found that 16% of patients received a prophylactic 
phenylephrine infusion. The median infusion start time for a 
prophylactic infusion was 19 minutes following SA [IQR 10-29]. 
Patients who did not receive a prophylactic phenylephrine infusion 
following SA had significantly increased risk of MAP <60mmHg for 
≥ 10 minutes (RR 3.42, 2.55-4.62, p<0.001). The observed median 
time to the first MAP <60 mmHg was longer in patients who 
received prophylactic phenylephrine infusions (80 [41-99] vs 29 
[16-57] minutes, p < 0.0001). Patients who were male, advanced 
age, higher physical status scores and history of CVD were more 
likely to receive a prophylactic infusion. 
This project is the first to establish the utilization rate of 
prophylactic phenylephrine infusions and the incidence of IOH 
after SA among orthopedic patients at a large academic health 








































Prophylactic Infusion: Phenylephrine infusion started prior to first MAP 
<60mmHg; Percent (#patients) at risk.
Table 1. Patient Demographic & Clinical Characteristics (n=3745)







Gender Female 50% (n=296) 55% (n=1735) 0.02
Male 50% (n=296) 45% (n=1418)
Physical Status I/II 66% (n=391) 71% (n=2239) 0.02
III/IV 34% (n=201) 29% (n=914)
Patient History DM 15% (n=86) 15% (n=464) 0.91
CKD 6% (n=35) 4% (n=134) 0.07
CAD 13% (n=78) 9% (n=286) <0.01
PVD 10% (n=61) 8% (n=244) 0.04
Stroke 10% (n=41) 8% (n=248) 0.43
Case Type Knee (TKA) 53% (n=315) 59% (n=1847) 0.02
Hip (THA) 46% (n=270) 39% (n=1238) <0.01
Other 1.0% (n=7) 2% (n=68) 0.12
Age (years) 69 (±10) 66 (±10) <0.01
BMI (kg/m2) 30 (±5) 30 (±5) 0.35
Case Duration (mins) 141 [123-155] 141 [123-155] 0.46
Prophylactic Infusion: Phenylephrine infusion started prior to first MAP <60mmHg; 
Continuous data presented as mean values (± standard deviation) or median 
[Interquartile Range]. Categorical data presented as a count and percent; BMI: Body 
Mass Index
Table 2. Incidence of IOH Following SA 
Prophylactic Phenylephrine Infusion versus No Infusion 
Figure 1. Time to First MAP <60mmHg 
With and without Prophylactic Infusion of Phenylephrine
Table 3. Number of Patients at Risk of MAP <60mmHg over Time
Prophylaxis: Infusion or bolus given prior to MAP <60mmHg; PI: 
Prophylactic phenylephrine infusion; PB: Prophylactic 
phenylephrine bolus; EB: Prophylactic ephedrine bolus
Cumulative survival (Kaplan-Meier) curves show the proportion of 









No Prophylaxis PI PI + PB/EB PB EB PB+EB
Figure 2. Analysis of IOH Treatment at PSHMC  
MAP Duration
IOH Incidence with and without 
Prophylaxis
Relative Risk of IOH 
No Prophylaxis
(mmHg) (mins) Prophylaxis No Prophylaxis RR 95% CI P value
<65 ≥ 20 20.3% (n=120) 42% (n=1309) 2.05 [1.74-2.42] <0.001
<60
≥ 10 7.1% (n=42) 24% (n=768) 3.42 [2.55-4.62] <0.001
≥ 20 3.2% (n=19) 12.9% (n=406) 4.01 [2.55-6.30] <0.001
<55 ≥ 5 4.2% (n=25) 12.6% (n=398) 2.99 [2.01-4.43] <0.001
≥ 10 1.2% (n=7) 5.4% (n=170) 4.56 [2.15-9.70] <0.001
<50
≥ 5 0.3% (n=2) 2.4% (n=76) 7.13 [1.76-29.0] 0.006
≥ 10 0.2% (n=1) 0.8% (n=25) 4.70 [0.64-34.6] 0.13
Categorical data presented as a percentage of the total; RR: Relative Risk Ratio
